Riskpilot← Back to searchSign inGet full accessISURGE AS
ASIn liquidationOrg 995261669Jerpefaret 33B, 0788 OsloMedical specialists activities · NACE 8622Est. 20105 employees
Revenue 2025
NOK 9,7M
-8% vs 2024
EBITDA margin
47.2%
+43% vs 2024
Equity ratio
84.2%
Financial strength
Net profit 2025
NOK 3,7M
+41% vs 2024
| Revenue | NOK 9,7M | -8% |
| EBITDA | NOK 4,6M | +43% |
| Net profit | NOK 3,7M | +41% |
| Total assets | NOK 7,7M | -29% |
| Equity | NOK 6,5M | -28% |
| Employees | 5 | — |
Legal name
ISURGE AS
Org number
995261669
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
8. mars 2010
Share capital
NOK 100 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Drive øyelegepraksis, investere i aksjer og liknende, leie ut, selge, kjøpe, eie og drive fast eiendom i inn- og utland, samt engasjere seg i selskap med liknende virksomhet, samt hva her står i forbindelse.
Address
Jerpefaret 33B, 0788 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 8 552 | 9 944 | 10 443 | 10 563 | 9 684 |
| Staff expenses | −846 | −1 251 | −2 023 | −2 730 | −1 734 |
| EBITDA | 2 941 | 4 236 | 3 754 | 3 201 | 4 572 |
| Depreciation & amort. | −394 | −420 | −372 | −166 | −42 |
| EBIT | 2 548 | 3 816 | 3 382 | 3 034 | 4 530 |
| Net financials | −0 | 2 | 109 | 332 | 118 |
| Profit before tax | 2 547 | 3 818 | 3 491 | 3 366 | 4 648 |
| Tax | 570 | 878 | 789 | 751 | 963 |
| Net profit | 1 978 | 2 940 | 2 702 | 2 615 | 3 685 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 472 | 6 712 | 9 448 | 10 818 | 7 712 |
| Equity | 2 432 | 5 372 | 8 074 | 9 009 | 6 494 |
| Long-term debt | 0 | 0 | 0 | 0 | 291 |
| Short-term debt | 1 041 | 1 340 | 1 374 | 1 809 | 927 |
| Total debt | 1 041 | 1 340 | 1 374 | 1 809 | 1 219 |
EBITDA margin
47.2%
This company
15.8%
Market median
+199% vs market
20212025
Equity ratio
84.2%
This company
38.2%
Market median
+120% vs market
20212025
Return on equity
56.7%
This company
18.4%
Market median
+208% vs market
20212025
Net profit margin
38.1%
This company
8.1%
Market median
+370% vs market
20212025
Asset turnover
1.26×
This company
1.12×
Market median
+12% vs market
20212025
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RJ Deputy Member | Deputy Member | 2010 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2010 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ISURGE AS 
BÆRUM ØYEKLINIKK ASBoard members of ISURGE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Reidar Jakobsen | Deputy Member | 0 companies |
| Jan Erik Jakobsen | Chairman | 0 companies |